Timber Pharmaceuticals Inc (TMBR) Down 4.52% in Premarket Trading

Wednesday, June 07, 2023 06:56 AM | InvestorsObserver Analysts

Mentioned in this article

Timber Pharmaceuticals Inc (TMBR) Down 4.52% in Premarket Trading

Timber Pharmaceuticals Inc (TMBR) is down Wednesday morning, with the stock losing -4.52% in pre-market trading to 1.69. TMBR's short-term technical score of 23 indicates that the stock has traded less bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 63 out of 146 industries, Timber Pharmaceuticals Inc ranks higher than 20% of stocks. Timber Pharmaceuticals Inc has risen 7.27% over the past month, closing at $1.57 on May 10. During this period of time, the stock fell as low as $1.34 and as high as $2.73. TMBR has an average analyst recommendation of Strong Buy. The company has an average price target of $11.00.

TMBR has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on TMBR!

See Full TMBR Report

Timber Pharmaceuticals Inc has a Long-Term Technical rank of 9. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 91% of the market scoring higher. In the Biotechnology industry which is number 71 by this metric, TMBR ranks better than 71% of stocks.

Important Dates for Investors in TMBR:

-Timber Pharmaceuticals Inc is set to release earnings on 8/13/2023. Over the last 12 months, the company has reported EPS of $-12.18. -We do not have a set dividend date for Timber Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Timber Pharmaceuticals Inc (TMBR)